文献速递疼痛医学术前评估与围术期医学

曲马多趋势:药理学、代谢与滥用

Trends in Tramadol: Pharmacology, Metabolism, and Misuse.
PubMed 文献 · Anesth Analg · 2017-01-01

曲马多是一种具有单胺能再摄取抑制和 opioid 受体激动双重作用的镇痛药,作为高亲和力 opioid 药物的替代品在全球越来越广泛用于急慢性疼痛。它是前药,经 CYP2D6 和 CYP3A4 代谢为活性代谢物 M1,其 opioid 镇痛效力受个体 CYP 遗传影响。本综述更新了曲马多的药理学、药代动力学、CYP 基因多态性、药物相互作用、毒性、戒断和非法使用等信息。

要点

  • 曲马多镇痛效力受 CYP2D6 基因型影响,慢代谢者转化 M1 少,超快代谢者 opioid 效应最强
  • 曲马多兼具 opioid 激动和 5-HT/NE 再摄取抑制,导致独特副作用和药物相互作用
  • 突然停用曲马多可增加 opioid 和 5-HT/NE 再摄取抑制剂戒断综合征风险

核心结论

  • 曲马多的镇痛效果和安全性受其独特双重机制及 CYP 基因多态性影响,临床需关注药物相互作用和戒断风险。

研究设计与样本

  • 本文为综述,检索范围未在摘要中明确报告。

主要发现

  • 曲马多经 CYP2D6 和 CYP3A4 代谢为活性代谢物 M1,CYP 遗传影响其 opioid 镇痛效力。
  • 曲马多兼具 opioid 受体激动和 5-HT/NE 再摄取抑制,导致独特副作用和药物相互作用。
  • 突然停用曲马多增加 opioid 和 5-HT/NE 再摄取抑制剂戒断综合征风险。

临床怎么用

  • 处方曲马多时应考虑患者 CYP 代谢表型,慢代谢者可能镇痛不足,超快代谢者 opioid 效应增强。
  • 需警惕曲马多与 5-HT 能药物等相互作用,并避免突然停药以减少戒断风险。

局限性

  • 本文为综述,未报告系统检索策略和纳入标准,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tramadol is a unique analgesic medication, available in variety of formulations, with both monoaminergic reuptake inhibitory and opioid receptor agonist activity increasingly prescribed worldwide as an alternative for high-affinity opioid medication in the treatment of acute and chronic pain. It is a prodrug that is metabolized by cytochrome P450 (CYP) enzymes CYP2D6 and CYP3A4 to its more potent opioid analgesic metabolites, particularly the O-demethylation product M1. The opioid analgesic potency of a given dose of tramadol is influenced by an individual's CYP genetics, with poor metabolizers experiencing little conversion to the active M1 opioid metabolite and individuals with a high metabolic profile, or ultra-metabolizers, experiencing the greatest opioid analgesic effects. The importance of the CYP metabolism has led to the adoption of computer clinical decision support with pharmacogenomics tools guiding tramadol treatment in major medical centers. Tramadol's simultaneous opioid agonist action and serotonin (5-HT) and norepinephrine reuptake inhibitory effects result in a unique side effect profile and important drug interactions that must be considered. Abrupt cessation of tramadol increases the risk for both opioid and serotonin-norepinephrine reuptake inhibitor withdrawal syndromes. This review provides updated important information on the pharmacology, pharmacokinetics, CYP genetic polymorphisms, drug interactions, toxicity, withdrawal, and illicit use of tramadol.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Miotto K, Cho AK, Khalil MA, et al. Trends in Tramadol: Pharmacology, Metabolism, and Misuse. Anesth Analg. 2017. PMID: 27861439

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。